In contrast, inhibiting ceramide synthesis in fat-fed streptozotocin (STZ)-treated rats has been shown to improve endothelial dysfunction by enhancing phosphorylation and NO release via the PI3K/Akt/eNOS pathway. Here, NOS3 is linked to endothelial dysfunction.